Target intelligence / Profile preview

novel transcript, antisense to SERPINI1 (ENSG00000287319)

Target: ENSG00000287319
Molecular classification: Non-coding RNA, Antisense transcript

Overview

The target described as 'novel transcript, antisense to SERPINI1' (ENSG00000287319) corresponds to an uncharacterized non-coding RNA discovered through genome annotation in the region antisense to the protein-coding SERPINI1 locus. Unlike SERPINI1, which codes for a serine protease inhibitor (neuroserpin), this transcript has not been functionally annotated and there are no reports suggesting it encodes a protein, serves as a drug target, or plays a direct role in disease. Its biological relevance and potential function are currently unknown.

Other names: Antisense RNA to SERPINI1novel antisense transcript at SERPINI1 locus

Biological functions

Unknown

Disease associations

Unknown

Beyond the preview

Go deeper on novel transcript, antisense to SERPINI1 (ENSG00000287319).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on novel transcript, antisense to SERPINI1 (ENSG00000287319).

Explore the full profile